Cerevel Therapeutics
CERE
#1994
Rank
$7.67 B
Marketcap
$42.27
Share price
-0.26%
Change (1 day)
79.49%
Change (1 year)

Cerevel Therapeutics (CERE) - Cash on Hand

Cash on Hand as of December 2023 : $0.99 B

According to Cerevel Therapeutics's latest financial reports the company has $0.99 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cerevel Therapeutics - Cash on Hand chart (from 2020 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.99 B11.09%
2022-12-31$0.89 B57.69%
2021-12-31$0.56 B47.46%
2020-12-31$0.38 B382.24%
2019-12-31$79.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$1.36 B 38.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.16 B-82.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.98 B 201.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.39 B 141.38%๐Ÿ‡บ๐Ÿ‡ธ USA